These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. The rocky road to effective treatment of human immunodeficiency virus (HIV) infection. Hirsch MS Ann Intern Med; 1989 Jan; 110(1):1-3. PubMed ID: 2642281 [No Abstract] [Full Text] [Related]
64. [Bluish pigmentation of the nails in AIDS patients. Possibly an adverse effect of Zidovudine?]. González Lahoz JM; García Aguado C; Martínez Fernández R; Laguna Cuesta F Rev Clin Esp; 1988 Oct; 183(5):278-9. PubMed ID: 2981033 [No Abstract] [Full Text] [Related]
65. Transient visual loss due to severe anemia in a patient with AIDS. Luchi M; Warren KA; Saberhagen C; Hinthorn D J La State Med Soc; 1999 Feb; 151(2):82-5. PubMed ID: 11280841 [TBL] [Abstract][Full Text] [Related]
66. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. Colson ER; Horwitz RI; Bia FJ; Viscoli CM Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453 [TBL] [Abstract][Full Text] [Related]
67. Lithium for zidovudine-induced neutropenia in AIDS. Herbert V; Hirschman S; Jacobson J JAMA; 1988 Dec 23-30; 260(24):3588. PubMed ID: 3193584 [No Abstract] [Full Text] [Related]
68. Zidovudine--AZT. Manser A Aust Nurses J; 1989 Apr; 18(9):37. PubMed ID: 2712762 [No Abstract] [Full Text] [Related]
69. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy. Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882 [TBL] [Abstract][Full Text] [Related]
70. [Ultrastructural study of azidothymidine-induced melanoderma in an AIDS patient]. Hermanns-Lê T; Gérardy-Goffin F; Giet-Lesuisse M; Piérard GE Ann Pathol; 1993; 13(5):328-31. PubMed ID: 8311859 [TBL] [Abstract][Full Text] [Related]
72. Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine. Klutman NE; Hinthorn DR N Engl J Med; 1991 Jun; 324(26):1896. PubMed ID: 2041557 [No Abstract] [Full Text] [Related]
73. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial. Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626 [TBL] [Abstract][Full Text] [Related]
74. Pharmacologic studies of nucleosides active against the human immunodeficiency virus. Sommadossi JP; Zhu Z; Carlisle R; Xie MY; Weidner DA Ann N Y Acad Sci; 1990; 616():356-66. PubMed ID: 2078028 [No Abstract] [Full Text] [Related]
75. Myopathy associated with AIDS. Marolda M; De Mercato R; Camporeale FS; Carandente M; Noce S; Cioffi M; Orsini AV; Cauli M; Bassi A Ital J Neurol Sci; 1989 Aug; 10(4):423-7. PubMed ID: 2793415 [TBL] [Abstract][Full Text] [Related]
76. Myalgias in human immunodeficiency virus-infected patients. Buskila D; Langevitz P Am J Med; 1989 Apr; 86(4):510-1. PubMed ID: 2929650 [No Abstract] [Full Text] [Related]
77. Analysis of myopathy in a placebo-controlled zidovudine trial. Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824 [No Abstract] [Full Text] [Related]